Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
Clinical trial NCT05788081 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05788081
- Sponsor
- Olivia Newton-John Cancer Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-31
- Primary completion
- 2027-01-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.